Lord, Abbett & Co
PRQR icon

Lord, Abbett & Co’s ProQR Therapeutics PRQR Stock Holding History

Lord, Abbett & Co’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-134,858
Closed -$2.95M – 970
2015
Q1 		$2.95M Sell
134,858
-18,066
-12% -$373K 0.01% 812
2014
Q4 		$3.31M Buy
152,924
+1,080
+0.7% +$16.4K 0.01% 794
2014
Q3 		$2.61M Buy
+151,844
New +$2.43M 0.01% 848

Other funds holding PRQR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Lord, Abbett & Co's PRQR Position: Q2 2015 in Review

Lord, Abbett & Co sold out of ProQR Therapeutics (PRQR) in Q2 2015, closing a stake of 134,858 shares — an estimated $2.95M sold.

Lord, Abbett & Co first reported a position in PRQR in Q3 2014 and held it in 3 quarters. The position peaked at $3.31M in Q4 2014. 37 funds tracked by Wall St. Rank hold PRQR as of Q2 2015.

  • Lord, Abbett & Co reported no remaining ProQR Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Lord, Abbett & Co sold 134,858 ProQR Therapeutics shares in Q2 2015, an estimated $2.95M.
  • Lord, Abbett & Co first reported a position in ProQR Therapeutics in Q3 2014 and held it in 3 quarters.
  • Lord, Abbett & Co's ProQR Therapeutics position peaked at $3.31M in Q4 2014.
  • 37 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q2 2015.

Based on Lord, Abbett & Co's 13F filing for Q2 2015, filed 14 Aug 2015.